Several key signaling pathways and hubs are altered in patients with PAH, such as the HIF1-signaling axis, BMPR2-TGFβ, PPARγ-signaling axis, and NF-κB-signaling [80]. Here, BMPR2 is linked to pulmonary arterial hypertension.